Skip to main content
Fig. 3 | Cancer Imaging

Fig. 3

From: How we read: the combined use of MRI and novel PET tracers for the characterisation and treatment planning of masses in neuro-oncology

Fig. 3

FDG-PET (a) in a patient with systemic lymphoma shows abnormal intracranial uptake (asterisk), consistent with secondary CNS involvement. This is localised to the hypothalamus on the post-contrast MRI (b). The post-contrast MRI (c) also demonstrates more extensive leptomeningeal disease than is appreciable on PET, including along the ependymal surface of the fourth ventricle (arrow)

Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us